Search results
Results from the WOW.Com Content Network
A by mouth formulation of leuprorelin is under development for the treatment of endometriosis. [61] It was also under development for the treatment of precocious puberty, prostate cancer, and uterine fibroids, but development for these uses was discontinued. [61] The formulation has the tentative brand name Ovarest. [61]
A 2004 study in which eleven men were chemically castrated ended with one committing suicide after one year of treatment; [7] in another 2020 study, increases in suicidal ideations was reported by 8% of its treatment group, which led to the hospitalization of two of the 25 subjects who had been administered degarelix. [8] [9]
A gonadotropin-releasing hormone agonist (GnRH agonist) is a type of medication which affects gonadotropins and sex hormones. [1] They are used for a variety of indications including in fertility medicine and to lower sex hormone levels in the treatment of hormone-sensitive cancers such as prostate cancer and breast cancer, certain gynecological disorders like heavy periods and endometriosis ...
Similarly, the Male Desire Scale (MDS) is used for men. [4] After evaluating symptom severity using the scales, patients are then prescribed different types of drugs. Flibanserin [1] and Bremelanotide [3] were developed for raising sexual desire in women, whereas similar conditions in men are treated using medications for sexual dysfunction. [4]
Male_Masturbation_with_Ejaculation_Video.webm (WebM audio/video file, VP8/Vorbis, length 1 min 15 s, 720 × 480 pixels, 851 kbps overall, file size: 7.6 MB) This is a file from the Wikimedia Commons .
Image credits: historycoolkids The History Cool Kids Instagram account has amassed an impressive 1.5 million followers since its creation in 2016. But the page’s success will come as no surprise ...
The idea of coming face to face with any spider-like creature is enough to fill any arachnophobe with horror, let alone encountering one with large, spiky legs.
Bicalutamide is used primarily in the treatment of early and advanced prostate cancer. [1] It is approved at a dosage of 50 mg/day as a combination therapy with a gonadotropin-releasing hormone analogue (GnRH analogue) or orchiectomy (that is, surgical or medical castration) in the treatment of stage D2 metastatic prostate cancer (mPC), [2] [3] and as a monotherapy at a dosage of 150 mg/day ...